J&J loses motion to overturn $4.7 billion talc verdict

 Healthcare conglomerate Johnson & Johnson has lost its motion to reverse a verdict that awarded $ 4.7 billion to women who blamed ovarian cancer on asbestos in the company’s Baby Powder and other talc products, a Missouri court ruled on Wednesday.

Shares of the company reversed course to slip 0.6 percent to $ 129.38 in afternoon trading.